To The Moon

0825 GMT - Singapore's gaming market and Genting Singapore are appealing defensive investment options in volatile markets, Citi analysts write in a note. The integrated-resorts operator is expected to be a major beneficiary of the visa-free arrangement between Singapore and China, Citi says. Genting Singapore could also benefit from the city-state's solid event lineup, including concerts, it adds. Citi maintains Genting Singapore's buy rating and target price of S$1.14. Shares are 0.6% lower at S$0.83.

Grab Holdings Limited , Southeast Asia's leading superapp, witnessed a pre-market surge of 5.21% on October 22, 2024, as investor sentiment remained bullish ahead of the company's highly anticipated third-quarter earnings release.The stock's upward momentum can be attributed to growing optimism about Grab's future growth prospects and expectations of positive results for the upcoming quarter. Grab is scheduled to release its unaudited third-quarter 2024 financial results after the U.S. market cl

Ride-hailing firm Grab stock gained another 5% in premarket trading Tuesday after jumping 8% on Monday. Grab plans to announce its unaudited third quarter 2024 results after the U.S. market closes on

Apple shares bucked the broader market's weekly selloff. Apple Inc.'s weekly stock gain wasn't too much to write home about in the absolute, but it was good enough to be the largest in the Dow Jones Industrial Average during a down period for the broader market amid geopolitical and interest-rate concerns.Shares of Apple climbed 4.1% on the week to beat out Nike Inc., the next-biggest gainer in the Dow DJIA with a 3.6% rally. Beyond those two stocks, no others saw weekly increases upwards of 1%, while the Dow on the whole fell 2.4% to record its biggest weekly percentage decline since March 2023.Don't miss: The bar is finally low enough for Nike, one analyst says. These big events could help the stock this year.Apple's placement atop the weekly Dow leaderboard is notable as the stock hadn't been the index's top such gainer since Nov. 10, 2023, when it closed out the week up 5.5%, according to Dow Jones Market Data.The feat is also significant as Apple shares have faced negative sentim

Feb 21 - Neurosense Therapeutics Ltd : * NEUROSENSE REPORTS ADDITIONAL POSITIVE RESULTS FROM ITS ALS PHASE 2B PARADIGM TRIAL * NEUROSENSE THERAPEUTICS LTD - PRIMEC DEMONSTRATED A CLINICALLY MEANINGFUL EFFECT ON QUALITY OF LIFE AND ON COMPLICATION FREE-SURVIVAL FOR PATIENTS WITH ALS * NEUROSENSE THERAPEUTICS LTD - FURTHER ANALYSIS OF PARADIGM IS ON TRACK WITH NEUROFILAMENT RESULTS EXPECTED IN Q1 * NEUROSENSE THERAPEUTICS LTD - TDP-43 AND PROSTAGLANDINJ2 BIOMARKERS EXPECTED IN FIRST HALF OF 2024 * NEUROSENSE THERAPEUTICS - STANDARD ALS MEASURE ALSFRS-R ALREADY SHOWED STATISTICALLY SIGNIFICANT EFFECT OF PRIMEC ON SLOWING DOWN DISEASE PROGRESSIONSource text for Eikon: Further company coverage:

Apple is pulling the plug on its credit-card partnership with Goldman Sachs, the final nail in the coffin of the Wall Street bank’s bid to expand into consumer lending.The tech giant recently sent a p

Ending weeks of speculation, the UK’s National Health Service has officially awarded a group led by Palantir Technologies (NYSE:PLTR) with a contract to overhaul the country's healthcare system, despi

The National Health Service (NHS) is set to assign the significant task of managing patient data and ashare of a 480m contractto U.S. spy tech firmPalantir Technologies Inc.What Happened: NHS England